Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease

Neurobiology of Aging

Volumn 25, Issue 2, 2004, Pages 149-157

  Zoia, Chiara ^a   Cogliati, Tiziana ^b   Tagliabue, Elena ^a   Cavaletti, Guido ^a   Sala, Gessica ^a   Galimberti, Gloria ^a   Rivolta, Ilaria ^c   Rossi, Vincenzo ^a   Frattola, Lodovico ^a   Ferrarese, Carlo ^a,d,e  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c IRCCS   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

Author keywords

EAAT2; EAAT3; Excitotoxicity; Glutamate uptake; Human peripheral marker; Molecular characterization

Indexed keywords

GLUTAMATE TRANSPORTER;

AGING; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MORPHOLOGY; NERVE DEGENERATION; NEUROPSYCHIATRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYNAPTOSOME; THROMBOCYTE;

EID: 9144232864     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00085-X     Document Type: Article

References (57)

1. Arriza J.L., Eliasof S., Kavanaugh M.P., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4155-4160.
2. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
3. Barbeau A., Campanella G., Butterworth R.F., Yamada K. Uptake and efflux 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease. Neurology. 25:1975;1-9.
4. Borroni B., Colciaghi F., Corsini P., Akkawi N., Rossini L., Del Zotto E.et al. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. Neurol. Sci. 23:2002;207-210.
5. Bristol L.A., Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39:1996;676-679.
6. Carrick T., Dunlop J. Protein kinase modulation of human excitatory amino acid transporter 2 subtype of glutamate transporter. Soc. Neurosci. 25:1999;170.5.
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. Coccia C., Ganel R., Rothstein J.D. GDNF induces an increase in EAAT2 (GLT-1) expression. Soc. Neurosci. 25:1999;170.2.
9. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F.et al. [Alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8(2):2002;67-74.
10. Conradt M., Stoffel W. Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J. Neurochem. 68:1997;1244-1251.
11. Coopert B., Chebib M., Shen J., King N.J., Darvey I.G., Kuchel P.W.et al. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch. Biochem. Biophys. 353(2):1998;356-364.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105.
13. Davis K.E., Straff D.J., Weinstein E.A., Bannerman P.G., Correale D.M., Rothstein J.D.et al. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. J. Neurosci. 18:1998;2475-2485.
14. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81(3):1999;163-221.
15. Dunlop J., Lou Z., McIlvain H.B. Properties of excitatory amino acid transport in human U373 astrocytoma cell line. Brain Res. 839:1999;235-242.
16. Fairman W.A., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature. 375:1995;599-603.
17. Ferrarese C., Begni B., Canevari C., Zoia C., Piolti R., Frigo M.et al. Glutamate uptake is decreased in platelets from Alzheimer patients. Ann. Neurol. 47:2000;641-643.
18. Ferrarese C., Sala G., Riva R., Begni B., Zoia C., Tremolizzo L.et al. the Italian ALS Study Group. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology. 56:2001;270-272.
19. Ferrarese C., Zoia C., Pecora N., Piolti R., Frigo M., Bianchi G.et al. Reduced platelet glutamate uptake in Parkinson's disease. J. Neural. Transm. 106:1999;685-692.
20. Folin M., Baiguera S., Conconi M.T., Pati T., Grandi C., Parnigotto P.P.et al. The impact of risk factors of Alzheimer's disease in the Down syndrome. Int. J. Mol. Med. 11:2003;267-270.
21. Franchi-Gazzola R., Visigalli R., Bussolati O., Gazzola G.C. Involvement of protein kinase Cε in the stimulation of anionic amino acid transport in cultured human fibroblasts. J. Biol. Chem. 42:1996;26124-26130.
22. Franconi F., Miceli M., Alberti L., Boatto G., Coinu R., De Montis M.G. et al. Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. Thromb. Res. 102(3):2001;255-260.
23. Franconi F., Miceli M., De Montis M.G., Crisafi E.L., Bennardini F., Tagliamonte A. NMDA receptors play an antiaggregating role in human platelets. Thromb. Haemost. 76:1996;84-87.
24. Genever P.G., Wilkinson D.J., Patton A.J., Peet N.M., Hong Y., Mathur A.et al. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 93(9):1999;2876-2883.
25. Ghosh S.S., Swerdlow R.H., Miller S.W., Scheeman B., Parker W.D. Jr., Davis R.E. Use of cytoplasmatic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann. NY Acad. Sci. 893:1999;176-191.
26. Gibson G.E., Huang H.M. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front. Biosci. 7:2002;d1007-d1015.
27. Jackson M., Song W., Liu M.Y., Jin L., Dykes-Hoberg M., Lin C.I.et al. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature. 410:2001;89-93.
28. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360:1992;467-471.
29. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R.et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 78(2):2001;413-416.
30. Lin C.G., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L.et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in Amiotrophic lateral sclerosis. Neuron. 20:1998;589-602.
31. Lin C.G., Orlov I., Ruggiero A.M., Dykes-Hoberg M., Lee A., Jackson M.et al. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature. 410:2001;84-88.
32. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
33. Longoni M., Tremolizzo L., Galimberti G., Vaccaro M., Ceresa C., Aliprandi A.et al. Platelet glutamate release after aggregation in normal subjects and in stroke patients. Func. Neurol. 16(2):2001;199.
34. Mangano R.M., Schwarcz R. The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J. Neurochem. 36:1981;1067-1076.
35. Marie H., Billups D., Bedford F., Attwell D., Moss S. Characterization of interaction between the LIM protein Ajuba and the glial glutamate transporter GLT-1, in COS cells and bipolar cells in slices of rat retina. J. Physiol. 525:2000;61P.
36. Marmo E. L-Glutamic acid as a neurotransmitter in the CNS. Med. Res. Rev. 8(3):1988;441-458.
37. Masliah E., Alford M., De Teresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40:1996;759-766.
38. Mennerick S., Dhond R.P., Benz A., Xu W., Rothstein J.D., Danbolt N.C.et al. Neuronal expression of the glutamate transporter GLT-1 in hippocampal microcultures. J. Neurosci. 18:1998;4490-4499.
39. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. TiPS. 11:1990;462-468.
40. Nicolini G., Miloso M., Zoia C., Di Silvestro A., Cavaletti G., Tredici G. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity. Anticancer Res. 18:1998;2477-2482.
41. Padovani A., Borroni B., Colciaghi F., Pettenati C., Cottini E., Agosti C.et al. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch. Neurol. 59:2002;71-75.
42. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L.et al. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360:1992;464-467.
43. Praticò D. Alzheimer's disease and oxygen radicals: new insights. Biochem. Pharmacol. 63:2002;563-567.
44. Robinson M.B., Gochenauer G.E., Rothstein J.D., Zelenaia O.A. Two Glast immunoreactive proteins in cultured astrocytes are differentially regulated by tumor necrosis factor α (TNFα) and protein kinase C (PKC). Soc. Neurosci. 25:1999;170.12.
45. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
46. Rothstein J.D., Martin L.J., Levey A.I., Dykes-Hoberg M., Jin L., Wu D. et al. Localization of neuronal and glial glutamate transporters. Neuron. 13:1994;713-725.
47. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;73-84.
48. Sims K.D., Straff D.J., Robinson M.B. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275(7):2000;5228-5237.
49. Scott H.L., Pow D.V., Tannenberg A.E.G., Dodd P.R. Abberant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J. Neurosci. 22:2002;RC206-RC210.
50. Skerry T.M., Genever P.G. Glutamate signalling in non-neuronal tissues. TiPS. 22(4):2001;174-181.
51. Sneddon J.M. Blood platelets as a model for monoamine-containing neurones. Prog. Neurobiol. 1:1973;151-198.
52. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10955-10959.
53. Tan J., Zelenaia O., Correale D., Rothstein J.D., Robinson M.B. Expression of the GLT-1 subtype of Na-dependent glutamate transporter: pharmacological characterization and lack of regulation by protein kinase C. JPET. 289:1999;1600-1610.
54. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K.et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1997;1699-1702.
55. Thai D.R. Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease. Brain Pathol. 12:2002;405-411.
56. Torp R., Lekieffre D., Levy L.M., Haug F.M., Danbolt N.C., Meldrum B.S. et al. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp. Brain Res. 103:1995;51-58.
57. Zieve P.D., Solomon H.M. Uptake of amino acids by the human platelet. Am. J. Physiol. 214:1968;58-61.